Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a retrospective case series study that included patients who performed deep anterior lamellar keratoplasty and presented with elevated intraocular pressure during follow up.
This is a retrospective case series study that included patients who performed deep anterior lamellar keratoplasty and presented with elevated intraocular pressure during follow up. Patients' demographic characteristics, medical, and ocular history will be recorded.
Inclusion criteria will include patients who were diagnosed with elevated intraocular pressure (IOP) after DALK surgery performed from 2018 to 2020 with follow up duration more than 6 months. Patients with less than 6 months of follow-up will be excluded from the study.
Patients' demographic characteristics, medical and ocular history will be recorded. Baseline complete ophthalmic examination was performed. It included best corrected visual acuity (BCVA) using Landolt C chart that was converted to log minimum angle of resolution (log MAR) for statistical analysis, slit lamp anterior segment examination (with attention to cornea, bulbar conjunctiva and AC), intraocular pressure measurement using rebound system (I care tonometer, Topcon, Canada), angle assessment and fundus examination using Goldman 3 mirror contact lens.
High IOP was defined as intraocular pressure more than 25 mmHg. Data will be collected with attention to appropriate management done either medical treatment or surgical intervention.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| antiglaucoma | Other | use antiglaucoma in ocular hypertension |
| Measure | Description | Time Frame |
|---|---|---|
| Intraocular pressure values | assessment of intraocular pressure after lamellar keratoplasty | this is a retrospective study . collection of data from patients records over 2 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
patients with DALK
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Amgad El Nokrashy, MD | Contact | 00201022187736 | amgad.ali@mans.edu.eg | |
| Aya Hashish, MD | Contact | 00201004701791 | aya.hashish@mans.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| AHMED El WEHEDY, MD | Mansoura University | Principal Investigator |
| Hatem El Awady, MD | Mansoura University | Study Chair |
| AYA HASHISH, MD |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mansoura university | Recruiting | Al Mansurah | Dakahlyia | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000089502 | Antiglaucoma Agents |
| ID | Term |
|---|---|
| D045506 | Therapeutic Uses |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
Not provided
Not provided
Not provided
Not provided
Not provided
| Mansoura University |
| Study Chair |
| AMGAD EL NOKRASHY, MD | Mansoura University | Study Chair |